Details

Autor(en) / Beteiligte

• Chen, Rong
• Daining, Conor P.
• Sun, Haiguo
• Fraser, Rheaclare
• Stokes, Stephanie L.
• Leitges, Michael
• Gnegy, Margaret E.

Titel

Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor‐activated trafficking of the dopamine transporter

Ist Teil von

• Journal of neurochemistry, 2013-06, Vol.125 (5), p.663-672

Ort / Verlag

England

Erscheinungsjahr

2013

Quelle

MEDLINE

Beschreibungen/Notizen

• The strength and duration of extracellular dopamine concentrations are regulated by the presynaptic dopamine transporter (DAT) and dopamine D2 autoreceptors (D2autoRs). There is a functional interaction between these two proteins. Activation of D2autoRs increases DAT trafficking to the surface whereas disruption of this interaction compromises activities of both proteins and alters dopaminergic transmission. Previously we reported that DAT expression and activity are subject to modulation by protein kinase Cβ (PKCβ). Here, we further demonstrate that PKCβ is integral for the interaction between DAT and D2autoR. Inhibition or absence of PKCβ abolished the communication between DAT and D2autoR. In mouse striatal synaptosomes and transfected N2A cells, the D2autoR‐stimulated membrane insertion of DAT was abolished by PKCβ inhibition. Moreover, D2autoR‐stimulated DAT trafficking is mediated by a PKCβ‐extracellular signal‐regulated kinase signaling cascade where PKCβ is upstream of extracellular signal‐regulated kinase. The increased surface DAT expression upon D2autoR activation resulted from enhanced DAT recycling as opposed to reduced internalization. Further, PKCβ promoted accelerated DAT recycling. Our study demonstrates that PKCβ critically regulates D2autoR‐activated DAT trafficking and dopaminergic signaling. PKCβ is a potential drug target for correcting abnormal extracellular dopamine levels in diseases such as drug addiction and schizophrenia. We proposed that increased dopamine transporter membrane insertion upon activation of dopamine D2 autoreceptor is because of enhanced recycling of the transporter. This trafficking is modulated by the PKCβ ‐ ERK signaling cascade with PKCβ upstream of ERK. Our findings suggest PKCβ as a new potential target for treatment of diseases with dysfunctional presynaptic dopaminergic transmission.